Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors
Authors:
- 21 November 2018
- journal article
- research article
- Published by Springer Nature in Journal of Community Genetics
- Vol. 10 (3) , 335-344
Abstract
Universal screening of all newly diagnosed colorectal cancer tumors can identify individuals at high risk for Lynch syndrome (LS), a hereditary cancer syndrome predisposing carriers to increased risk of colorectal, endometrial, and other cancers. To inform planning of a universal tumor screening program for LS in our jurisdiction, we undertook online surveys of Canadian pathologists and genetic counselors to describe existing tumor screening programs. Online surveys were hosted on SurveyMonkey between October 2016 and March 2017. Fifty-three pathologists and 66 genetic counselors completed surveys (total n = 119). While attitudes towards tumor screening were positive, considerable variability was observed in the existence of tumor screening, test ordering criteria, and practices. Most respondents indicated consent was not obtained for tumor screening nor were educational materials provided to patients; however, opting out of additional mutation testing in the event of a positive tumor screen was endorsed. Results add to the growing literature on providers’ perspectives on population-based tumor screening programs and inform ways to offer these. Findings highlight the need to develop methods of patient education that allow meaningful opt-out decisions. The variability we observed also suggests the need for national standards and guidance on tumor screening for LS.Keywords
This publication has 50 references indexed in Scilit:
- Universal tumor screening for Lynch syndrome: health-care providers’ perspectivesGenetics in Medicine, 2017
- Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysisJournal of Clinical Pathology, 2015
- Current Lynch Syndrome Tumor Screening Practices: A Survey of Genetic CounselorsJournal of Genetic Counseling, 2013
- Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancerGenetics in Medicine, 2013
- Reflex Immunohistochemistry and Microsatellite Instability Testing of Colorectal Tumors for Lynch Syndrome Among US Cancer Programs and Follow-Up of Abnormal ResultsJournal of Clinical Oncology, 2012
- Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meetingGenetics in Medicine, 2012
- Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndromeGenetics in Medicine, 2011
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenetics in Medicine, 2009
- Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutationsClinical Genetics, 2008
- Microsatellite InstabilityNew England Journal of Medicine, 2003